To explore whether heteroarene-fused anthraquinones 2a–c possess anticancer properties against oral cancer cells, we used cell impedance measurement to evaluate the cell growth profiles of two human oral squamous carcinoma cell lines with varied p53 functionality: SAS and HSC-3 cells. The gene discussed is TP53; the disease is lip and oral cavity carcinoma.